EP Patent
EP2431358A1 — Method of preparing a factor XA inhibitor
Assigned to Millennium Pharmaceuticals Inc · Expires 2012-03-21 · 14y expired
What this patent protects
The present invention is also directed to methods of making the compound of Formula I. and salts thereof.
USPTO Abstract
The present invention is also directed to methods of making the compound of Formula I. and salts thereof.
Drugs covered by this patent
- Bevyxxa (BETRIXABAN) · Portola Pharms Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.